20
Sanofi-aventis Deutschland Gmbh Frankfurt Am Main De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Methadone hydrochloride, Alternative grade, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2015-358 - Rev 00
This Chemical Type CEP, issued on May 24, 2016, remains in force until September 04, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 408 associated with this CEP further emphasizes